Agile Therapeutics (AGRX) Reports Q2 Loss of $0.27/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/16/2026

1. VRNS
2. JBHT
3. CRWV
4. TSLA
5. GPRK
6. SCHW
7. TRV
8. TFC
9. NVDA
10. POLYCAB:IN

Go back to Agile Therapeutics (AGRX) Reports Q2 Loss of $0.27/Share

Agile Therapeutics Reports Second Quarter 2017 Financial Results

July 28, 2017 7:30 AM EDT

Cash Expected to Fund Operations into Q2 2018

FDA Assigns Prescription Drug User Fee Act (PDUFA) Goal Date of December 26, 2017

PRINCETON, N.J., July 28, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company today reported financial results for the three and six months ended June 30, 2017, and provided a corporate update for the second quarter 2017.

Second quarter 2017 and other recent corporate developments include:     

... More